Work

Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer

Year: 2002

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.20.3.727

Authors: F.A. Holmes, J.A. O’Shaughnessy, S. Vukelja, S.E. Jones, J. Shogan, M. Savin, J. Glaspy, M. Moore, L. Meza, I. Wiznitzer, T.A. Neumann, L.R. Hill, B.C. Liang

Institutions: Amgen (United States), University of California, Los Angeles, Los Angeles Medical Center, Georgia Cancer Specialists

Language: English

Topic: Neutropenia and Cancer Infections

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2115170812

FWCI: 14.6

Cites: 12

Cited by: 538

Related to: 10